RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Cetuximab in non-small-cell lung cancer.
2012-01-01 Carillio G;Montanino A;Costanzo R;Sandomenico C;Piccirillo MC;Di Maio M;Daniele G;Giordano P;Bryce J;Normanno N;Rocco G;Perrone F;Morabito A
Challenges and controversies in resectable non-small cell lung cancer: a clinician's perspective
2024-01-01 Houda, Ilias; Dickhoff, Chris; Uyl-de Groot, Carin A; Damhuis, Ronald A M; Reguart, Noemi; Provencio, Mariano; Levy, Antonin; Dziadziuszko, Rafal; Pompili, Cecilia; Di Maio, Massimo; Thomas, Michael; Brunelli, Alessandro; Popat, Sanjay; Senan, Suresh; Bahce, Idris
Chemotherapy and intercalated gefitinib or erlotinib in the treatment of advanced non-small-cell lung cancer
2017-01-01 Rossi, Antonio; La Salvia, Anna; Di Maio, Massimo
Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer
2018-01-01 Trestini I.; Carbognin L.; Monteverdi S.; Zanelli S.; De Toma A.; Bonaiuto C.; Nortilli R.; Fiorio E.; Pilotto S.; Di Maio M.; Gasbarrini A.; Scambia G.; Tortora G.; Bria E.
Combining anti-Epidermal Growth Factor Receptor (EGFR) and anti-angiogenic strategies in advanced NSCLC: we should have known better….
2014-01-01 Di Maio M;Morabito A;Piccirillo MC;Daniele G;Giordano P;Costanzo R;Sandomenico C;Montanino A;Rocco G;Perrone F
Cons: Should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
2018-01-01 Metro G.; Di Maio M.
Conventional chemotherapy of advanced pancreatic cancer.
2012-01-01 Giuliani F;Di Maio M;Colucci G;Perrone F
COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave?
2021-01-01 Silvestris N.; Di Maio M.; Russo A.; Chiari R.; De Giorgi U.; Del Mastro L.; Giuffrida D.; La Verde N.; Perrone F.; Tucci M.; Beretta G.D.; Cinieri S.
Diagnostic and therapeutic issues for patients with advanced non‑small cell lung cancer harboring anaplastic lymphoma kinase rearrangement: European vs. US perspective (review).
2014-01-01 Di Maio M;De Marinis F;Hirsch FR;Gridelli C
Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer
2020-01-01 Liang, Wenhua; Cai, Kaican; Chen, Chun; Chen, Haiquan; Chen, Qixun; Fu, Junke; Hu, Jian; Jiang, Tao; Jiao, Wenjie; Li, Shuben; Liu, Changhong; Liu, Deruo; Liu, Wei; Liu, Yang; Ma, Haitao; Pan, Xiaojie; Qiao, Guibin; Tian, Hui; Wei, Li; Zhang, Yi; Zhao, Song; Zhao, Xiaojing; Zhou, Chengzhi; Zhu, Yuming; Zhong, Ran; Li, Feng; Rosell, Rafael; Provencio, Mariano; Massarelli, Erminia; Antonoff, Mara B; Hida, Toyoaki; de Perrot, Marc; Lin, Steven H; Di Maio, Massimo; Rossi, Antonio; De Ruysscher, Dirk; Ramirez, Robert A; Dempke, Wolfram C M; Camidge, D Ross; Guibert, Nicolas; Califano, Raffaele; Wang, Qi; Ren, Shengxiang; Zhou, Caicun; He, Jianxing
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cetuximab in non-small-cell lung cancer. | 2012 | Carillio G;Montanino A;Costanzo R;Sandomenico C;Piccirillo MC;Di Maio M;Daniele G;Giordano P;Bryce J;Normanno N;Rocco G;Perrone F;Morabito A | |
| Challenges and controversies in resectable non-small cell lung cancer: a clinician's perspective | 2024 | Houda, Ilias; Dickhoff, Chris; Uyl-de Groot, Carin A; Damhuis, Ronald A M; Reguart, Noemi; Provencio, Mariano; Levy, Antonin; Dziadziuszko, Rafal; Pompili, Cecilia; Di Maio, Massimo; Thomas, Michael; Brunelli, Alessandro; Popat, Sanjay; Senan, Suresh; Bahce, Idris | |
| Chemotherapy and intercalated gefitinib or erlotinib in the treatment of advanced non-small-cell lung cancer | 2017 | Rossi, Antonio; La Salvia, Anna; Di Maio, Massimo | |
| Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer | 2018 | Trestini I.; Carbognin L.; Monteverdi S.; Zanelli S.; De Toma A.; Bonaiuto C.; Nortilli R.; Fiorio E.; Pilotto S.; Di Maio M.; Gasbarrini A.; Scambia G.; Tortora G.; Bria E. | |
| Combining anti-Epidermal Growth Factor Receptor (EGFR) and anti-angiogenic strategies in advanced NSCLC: we should have known better…. | 2014 | Di Maio M;Morabito A;Piccirillo MC;Daniele G;Giordano P;Costanzo R;Sandomenico C;Montanino A;Rocco G;Perrone F | |
| Cons: Should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer? | 2018 | Metro G.; Di Maio M. | |
| Conventional chemotherapy of advanced pancreatic cancer. | 2012 | Giuliani F;Di Maio M;Colucci G;Perrone F | |
| COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave? | 2021 | Silvestris N.; Di Maio M.; Russo A.; Chiari R.; De Giorgi U.; Del Mastro L.; Giuffrida D.; La Verde N.; Perrone F.; Tucci M.; Beretta G.D.; Cinieri S. | |
| Diagnostic and therapeutic issues for patients with advanced non‑small cell lung cancer harboring anaplastic lymphoma kinase rearrangement: European vs. US perspective (review). | 2014 | Di Maio M;De Marinis F;Hirsch FR;Gridelli C | |
| Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer | 2020 | Liang, Wenhua; Cai, Kaican; Chen, Chun; Chen, Haiquan; Chen, Qixun; Fu, Junke; Hu, Jian; Jiang, Tao; Jiao, Wenjie; Li, Shuben; Liu, Changhong; Liu, Deruo; Liu, Wei; Liu, Yang; Ma, Haitao; Pan, Xiaojie; Qiao, Guibin; Tian, Hui; Wei, Li; Zhang, Yi; Zhao, Song; Zhao, Xiaojing; Zhou, Chengzhi; Zhu, Yuming; Zhong, Ran; Li, Feng; Rosell, Rafael; Provencio, Mariano; Massarelli, Erminia; Antonoff, Mara B; Hida, Toyoaki; de Perrot, Marc; Lin, Steven H; Di Maio, Massimo; Rossi, Antonio; De Ruysscher, Dirk; Ramirez, Robert A; Dempke, Wolfram C M; Camidge, D Ross; Guibert, Nicolas; Califano, Raffaele; Wang, Qi; Ren, Shengxiang; Zhou, Caicun; He, Jianxing |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 03-CONTRIBUTO IN RIVISTA 75
- 03-CONTRIBUTO IN RIVISTA::03B-Rev... 75
Data di pubblicazione
- 2020 - 2024 25
- 2010 - 2019 50
Rivista
- CRITICAL REVIEWS IN ONCOLOGY HEMA... 13
- CANCER TREATMENT REVIEWS 5
- EXPERT REVIEW OF ANTICANCER THERAPY 5
- LUNG CANCER 4
- TRANSLATIONAL LUNG CANCER RESEARCH 3
- CLINICAL LUNG CANCER 2
- ENDOCRINE-RELATED CANCER 2
- ESMO OPEN 2
- EXPERT OPINION ON BIOLOGICAL THERAPY 2
- JOURNAL OF CLINICAL ONCOLOGY 2
Keyword
- Humans 16
- Immunotherapy 9
- Oncology 8
- Immune checkpoint inhibitors 6
- Neoplasms 5
- Antineoplastic Agents 4
- Biomarkers 3
- Carcinoma 3
- Clinical Trials as Topic 3
- Hematology 3
Lingua
- eng 72
- Inglese 2
- ita 1
Accesso al fulltext
- no fulltext 24
- open 23
- reserved 18
- partially open 9
- mixed 1